Dr. Oliver G. Abela, MD
Hospitalist (Hospitalist Physician)
- Medicare participating
At a glance
- Years since graduation
- 16
- In the NPI registry since
- 2010
- Medicare patients seen, 2024
- 338
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2010Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Hospitalist Physician primary
FL license ME136178 -
Advanced Heart Failure and Transplant Cardiology Physician
FL license ME136178 -
Cardiovascular Disease Physician
FL license ME136178 -
Internal Medicine Physician
MI license 4301096300 -
Interventional Cardiology Physician
FL license ME136178
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- St Josephs Hospital Tampa, FL
- Tampa General Hospital Tampa, FL
- Adventhealth Tampa Tampa, FL
- HCA Florida South Tampa Hospital Tampa, FL
Medical groups
- University of Miami (2,377 clinicians)
- Lee Health System Inc (1,428 clinicians)
- West Florida Cardiovascular Co-Management Associates, LLC (37 clinicians)
- Vh Provider Group PA (9 clinicians)
- Tampa Heart and Vascular Associates LLC (3 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 338
- Services billed
- 1,299
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 376 | 275 |
| Established patient office or other outpatient visit, 40-54 minutes | 203 | 126 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 180 | 172 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 148 | 54 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 82 | 73 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 77 | 74 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 70 | 16 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 67 | 56 |
| Established patient office or other outpatient visit, 30-39 minutes | 43 | 39 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 42 | 41 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Atorvastatin Calcium Other prescribers in Fort Myers, FL | 217 |
| Eliquis (apixaban) Other prescribers in Fort Myers, FL | 149 |
| Clopidogrel (clopidogrel bisulfate) Other prescribers in Fort Myers, FL | 119 |
| Amlodipine Besylate Other prescribers in Fort Myers, FL | 104 |
| Rosuvastatin Calcium Other prescribers in Fort Myers, FL | 98 |
| Metoprolol Succinate Other prescribers in Fort Myers, FL | 96 |
| Carvedilol Other prescribers in Fort Myers, FL | 83 |
| Losartan Potassium Other prescribers in Fort Myers, FL | 77 |
| Farxiga (dapagliflozin propanediol) Other prescribers in Fort Myers, FL | 61 |
| Valsartan Other prescribers in Fort Myers, FL | 59 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 20 companies reported 111 payments worth $13,929 in total to this clinician.
| Procyrion, Inc. | $9,138 |
|---|---|
| Stryker Corporation | $1,080 |
| Abiomed | $1,027 |
| Medtronic, Inc. | $701 |
| Inari Medical, Inc. | $384 |
| Kestra Medical Technology Services, Inc. | $260 |
| Abbott Laboratories | $247 |
| Alnylam Pharmaceuticals Inc. | $227 |
| Consulting Fee | $9,000 |
|---|---|
| Food and Beverage | $4,929 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Procyrion, Inc. Feb 13, 2025 | Consulting Fee AORTIX SYSTEM · CARDIAC ARRHYTHMIAS AND HEART FAILURE | $9,000 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 2 companies. The companies reported $56,306 in research payments for these studies, mostly to the institutions running them.
- Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
Procyrion, Inc. · Recruiting · NCT05677100 - BIOFLOW-VII
Biotronik Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.